Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Oct 1.

Published in final edited form as: Biochim Biophys Acta. 2012 Jul 3;1822(10):1638–1642. doi: 10.1016/j.bbadis.2012.06.012

Fig. 2 — Human peripheral blood neutrophils were incubated with 0.01–10 µM DHEA-S, 0.01 µM roflumilast or 1 µM dexamethasone for 4 h, transferred to transwell inserts and allowed to migrate in the presence of 10 nM fMLP for 2 h (A) and (B). Inhibition by treatment with compounds (B) was expressed as a percentage of fMLP stimulated alone (set at 100%). Data is representative of three to seven measurements per condition tested (* p<0.0001)

Fig. 2 — Human peripheral blood neutrophils were incubated with 0.01–10 µM DHEA-S, 0.01 µM roflumilast or 1 µM dexamethasone for 4 h, transferred to transwell inserts and allowed to migrate in the presence of 10 nM fMLP for 2 h (A) and (B). Inhibition by treatment with compounds (B) was expressed as a percentage of fMLP stimulated alone (set at 100%). Data is representative of three to seven measurements per condition tested (* p<0.0001)